
Ankit Malik
@ankitmalik06
Assistant Professor
University of North Carolina
ID: 2602163522
03-07-2014 19:50:06
69 Tweet
59 Followers
174 Following






A new year and a new Inflammazoom. The next exciting instalment will be from Eicke Latz and @russellevance. You may be feeling a bit of a zoombie, but don't miss these exciting talks!


New pre-print describing heterogeneity in IBD to inform therapeutic strategies. Great work! @MathildePohin @matta_jackson Ilya Korsunsky


@evolscientist Ran Blekhman Harmit S. Malik The real solution is most likely at the policy level. Universities and funding agencies have the power to implement strategies to track abusive PIs, protect people who work with them, and prevent them from being able to hire more without supervision.

Please RT! Looking for a PhD student to bridge laboratory & field for vaccine/immunotherapy development for Tasmanian devil transmissible cancers. Veterinarians encouraged to apply. Andy Flies tinyurl.com/bbfwd79c. University of Tasmania Menzies Institute for Medical Research WACImmuno





Sensing of interferon-γ triggers antigen presentation by colonic epithelial cells, enabling T cells to lower extracellular ATP levels and reduce inflammation nature.com/articles/s4159… Nature Immunology Comment on nature.com/articles/s4158… Bana Jabri Ankit Malik

Out now! Gut bacteria encode an unprecedented number of enzymes for anaerobic respiration of biomedically relevant substrates by Sam Light Ashley Sidebottom Michael Mullowney A. Murat Eren (Meren) Matthew S. Schechter Kaylie Scorza Deepti Sharan Emily Waligurski Matt Odenwald nature.com/articles/s4156…

💡 UChicagoCancerCenter researchers unveiled the secrets of epithelial cells to battle IBD and prevent colorectal cancer! 🔬🔍🧬🦠 UChicago Biological Sciences Bana Jabri #AnkitMalik Nature Portfolio UChicago Digestive Diseases #BreakthroughScience #HealthInnovation ow.ly/orIs50QwSOT


I'm deeply honored and grateful to receive the 2024 Young Investigator Award by the Cancer Research Foundation. This funding will boost our research on ion channels in the context of tumor immunotherapy.